Cost-effectiveness of antigen testing for ending COVID-19 isolation
View ORCID ProfileSigal Maya, James G. Kahn
doi: https://doi.org/10.1101/2022.03.21.22272687
Sigal Maya
1Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, CA, USA
MSJames G. Kahn
1Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, CA, USA
MD MPHArticle usage
Posted March 21, 2022.
Cost-effectiveness of antigen testing for ending COVID-19 isolation
Sigal Maya, James G. Kahn
medRxiv 2022.03.21.22272687; doi: https://doi.org/10.1101/2022.03.21.22272687
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (678)
- Anesthesia (182)
- Cardiovascular Medicine (2678)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12310)
- Forensic Medicine (10)
- Gastroenterology (769)
- Genetic and Genomic Medicine (4156)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2693)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3931)
- Nursing (212)
- Nutrition (584)
- Oncology (2070)
- Ophthalmology (595)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1130)
- Primary Care Research (461)
- Public and Global Health (6577)
- Radiology and Imaging (1420)
- Respiratory Medicine (876)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)